Trial Profile
Pilot-Trial: Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Jul 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Dalteparin sodium; Phenprocoumon
- Indications Thrombosis
- Focus Adverse reactions; Therapeutic Use
- 15 Aug 2016 Status changed from recruiting to discontinued due to safety reasons.
- 12 Oct 2011 New trial record